Provectus Biopharmaceuticals (PVCT) null Earnings

12AugConfirmed
Q3 2019
Feb 20
May 20
Aug 20
-0
-0
-0
-0

Details

Expected EPS
N/A
Actual EPS
-0.004
Surprise EPS
-0
Surprise Percent
+∞%

Description

Provectus Biopharmaceuticals (PVCT) has reported earnings of -0.004 per share for .

0 Comments

Share your thoughts